Cytal
Integra LifeSciences
Description
Versatile range of dermal matrices with varying resorption profiles which allow to obtain wound coverage and tissue deposition for the duration that is required. An extracellular matrix (ECM) derived from porcine urinary bladder matrix (UBM) technology, it provides an environment that supports new tissue formation and wound healing. It is acellular, minimally processed, non-crosslinked and completely resorbable, and it is associated with a modified inflammatory response.
Indications
Management of wounds including: partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor sites/grafts, post-Moh’s surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns, skin tears) and draining wounds
Contraindications
Sensitivity or allergy to porcine materials; third-degree burns
Price
1-layer (3×3,5cm), 1-layer (3×7cm), 1-layer (7×10cm), 1-layer (10×15cm), 2-layer (5×5cm), 2-layer (7×10cm), 2-layer (10×15cm), 3-layer (5×5cm), 3-layer (7×10cm), 3-layer (10×15cm), 6-layer (5×5cm), 6-layer (7×10cm), 6-layer (10×15cm), not on Drug Tariff